* Applied DNA Sciences Inc is expected to show a rise in quarterly revenue when it reports results on December 12 (estimated) for the period ending September 30 2024
* The Stony Brook New York-based company is expected to report a 15.3% increase in revenue to $899 thousand from $780 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
* LSEG's mean analyst estimate for Applied DNA Sciences Inc is for a loss of 34 cents per share.
* The one available analyst rating on the shares is "hold".
* The mean earnings estimate of analysts was unchanged in the last three months.
This summary was machine generated December 10 at 21:14 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments